Microbot Medical MBOT Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's cash provided by (used in) investing activity, including discontinued operation?
- Microbot Medical (MBOT) reported cash provided by (used in) investing activity, including discontinued operation of $5M in Q1 2026.
- How has Microbot Medical's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Microbot Medical's cash provided by (used in) investing activity, including discontinued operation increased by 120.1% year-over-year, from -$24.83M to $5M.
- What is the long-term trend for Microbot Medical's cash provided by (used in) investing activity, including discontinued operation?
- Over 2 years (2022 to 2025), Microbot Medical's cash provided by (used in) investing activity, including discontinued operation has grown at a 334.4% compound annual growth rate (CAGR), from -$3.84M to -$72.38M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.